866923-62-8: Montelukast Nitrile Impurity

866923-62-8: Montelukast Nitrile Impurity

Montelukast Nitrile Impurity (CAS No: 866923-62-8) is an impurity present in the synthesis of montelukast which is used as an effective and well-tolerated oral treatment for allergic airway inflammation in patients with SAR or PAR without asthma.

Additional information on CAS 866923-62-8

Catalogue No.

VL510004
CAS No.

866923-62-8
Molecular Formula

C₃₅H₃₅ClN₂OS
Molecular Weight

567.18
Parent drug

Montelukast
IUPAC Name

1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetonitrile
Synonyms

1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetonitrile
Smiles

CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC#N)O
References

Barnabas, K. Samuel, et al. “A Novel Stability-Indicating Method for Determination of Related Substances of Montelukast Sodium in a Pharmaceutical Dosage Form Using RP-HPLC.” Chromatographia, vol. 84, no. 7, June 2021, pp. 645–62, https://doi.org/10.1007/s10337-021-04045-8. ?Wang, D. “Simultaneous Determination of Montelukast Sodium S-Enantiomer and A5 Enantiomers in Montelukast Sodium Bulk Drug by Normal-Phase Chiral HPLC.” Indian Journal of Pharmaceutical Sciences, vol. 79, no. 01, 2017, http
Status

In-stock

Other products related to montelukast

[rfq_list]

Login first to add product to RFQ List

Request a quote

866923-62-8: Montelukast Nitrile Impurity

866923-62-8: Montelukast Nitrile Impurity
Catalogue No.

VL510004
CAS No.

866923-62-8
Molecular Formula

C₃₅H₃₅ClN₂OS
Molecular Weight

567.18
Parent drug

Montelukast
IUPAC Name

1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetonitrile
Synonyms

1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetonitrile
Smiles

CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC#N)O
References

Barnabas, K. Samuel, et al. “A Novel Stability-Indicating Method for Determination of Related Substances of Montelukast Sodium in a Pharmaceutical Dosage Form Using RP-HPLC.” Chromatographia, vol. 84, no. 7, June 2021, pp. 645–62, https://doi.org/10.1007/s10337-021-04045-8. ?Wang, D. “Simultaneous Determination of Montelukast Sodium S-Enantiomer and A5 Enantiomers in Montelukast Sodium Bulk Drug by Normal-Phase Chiral HPLC.” Indian Journal of Pharmaceutical Sciences, vol. 79, no. 01, 2017, http
Status

In-stock
ListName

Montelukast Nitrile Impurity
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden